Mangalam Drugs And Organics Limited — Board Meeting, 13-02-2025: Outcome of Board Meeting

The Board of Directors of Mangalam Drugs and Organics Limited has approved the unaudited financial results for the quarter and nine months ended December 31, 2024. Total income from operations stood at ₹88.71 crore, while the net profit for the period was ₹14.03 crore. The company's expenses totaled ₹83.88 crore, resulting in a profit from operations before tax of ₹1.48 crore. The statutory auditors expressed an unmodified opinion on these results, indicating a clean review. This meeting reaffirmed the company's continued focus on strategic growth and operational efficiency.